Adjuvant immune checkpoint blockade revisited by van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh, Huisman, Atse, Roy, Anke Pisters-van, Koole, Simone, Timmers, Lonneke, Blank, Christian, Gelderblom, Hans

Get full text

Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform by Zeverijn, Laurien J, van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh, van Roy, Anke A M G Pisters, Timmers, Lonneke, Ly Tran, T H, de Boer, Jolanda E, de Wit, Gijsbrecht F, Geurts, Birgit S, Gelderblom, Hans, Verheul, Henk M W, Blijlevens, Nicole, Wymenga, A N Machteld, Eskens, Ferry A L M, Smit, Egbert F, Bloemendal, Haiko J, Voest, Emile E

Get full text

Outcome-based reimbursement in Central-Eastern Europe and Middle-East by Ádám, Ildikó, Callenbach, Marcelien, Németh, Bertalan, Vreman, Rick A., Tollin, Cecilia, Pontén, Johan, Dawoud, Dalia, Elvidge, Jamie, Crabb, Nick, van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh, Pisters-van Roy, Anke, Vincziczki, Áron, Almomani, Emad, Vajagic, Maja, Oner, Z. Gulsen, Matni, Mirna, Fürst, Jurij, Kahveci, Rabia, Goettsch, Wim G., Kaló, Zoltán

Get full text

Manufacturers' views on outcome-based agreements by Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Timmers, Lonneke, Pisters-van Roy, Anke, Gijzen, Joël, Blijlevens, Nicole M.A., Bloemendal, Haiko

Get full text